Advanced Search

 

Study ID Status Title Patient Level Data
FLN-203 Completed Title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of once- versus twice-daily intranasal administration of aqueous fluticasone proprionate for two weeks in adult patients with seasonal allergic rhinitis
FLN-204 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of once- versus twice-daily intranasal administration of aqueous fluticasone propionate for four weeks in adult patients with seasonal allergic rhinitis
FLN-230 Completed A double-blind, double-dummy, randomized, parallel group comparison of the efficacy of intranasal and oral fluticasone propionate in patients with seasonal allergic rhinitis.
FLN-260 Completed A double-blind, placebo-controlled, dose-tolerance study to assess the effects of fluticasone propionate aqueous nasal spray versus oral prednisone on the HPA axis
FLN-270 Completed A double-blind, randomized, placebo-controlled, parallel group study comparing fluticasone propionate aqueous nasal spray 200µg QD manufactured with two different procedures in patients with seasonal allergic rhinitis
FLN-305 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once- versus twice-daily versus placebo for two weeks in adolescent patients with seasonal allergic rhinitis
FLN-306 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once- versus twice-daily versus aqueous beclomethasone dipropionate versus placebo for four weeks in adult and adolescent patients with seasonal allergic rhinitis.
FLN-320 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once daily versus placebo for two weeks in pediatric patients with seasonal allergic rhinitis
FLN-350 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of two doses of fluticasone propionate aqueous nasal spray given twice daily versus placebo for four weeks in patients with perennial nonallergic rhinitis
FLN-351 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of fluticasone propionate aqueous nasal spray given twice daily versus placebo for four weeks in patients with perennial nonallergic rhinitis
FLN-401 Completed A double-blind, double-dummy, randomized, parallel group comparison of the efficacy and safety of fluticasone propionate aqueous nasal spray 200mcg QD versus terfenadine 60mg BID versus placebo for two weeks in patients with seasonal allergic rhinitis in the mountain cedar season.
FLN-402 Completed A double-blind, double-dummy, randomized, parallel group comparison of the efficacy and safety of fluticasone propionate aqueous nasal spray 200mcg QD versus terfenadine 60mg BID versus placebo for four weeks in patients with seasonal allergic rhinitis
FLN-403 Completed The effects of fluticasone propionate aqueous nasal spray vs terfenadine tablets on the nasal mucosa: a one year nasal biopsy study in patients with perennial allergic rhinitis
FLN-411 Completed A double-blind, double-dummy, randomized, parallel group comparison of the efficacy and safety of fluticasone propionate aqueous nasal spray 200mcg QD versus astemizole 10mg QD versus placebo for two weeks in patients with seasonal allergic rhinitis
FLN-412 Completed A double-blind, double-dummy, randomized, parallel group comparison of the efficacy and safety of fluticasone propionate aqueous nasal spray 200mcg QD versus astemizole 10mg QD versus placebo for four weeks in patients with seasonal allergic rhinitis.
FLN-442 Completed A double-blind, placebo-controlled, parallel group comparison of FlonaseTM nasal spray and Beconase AQ® nasal spray in patients with seasonal allergic rhinitis
FLN-443 Completed A double-blind, placebo-controlled, parallel group comparison of FlonaseTM nasal spray and Beconase AQ® nasal spray in patients with seasonal allergic rhinitis
FLN-444 Completed A double-blind, placebo-controlled, randomized, parallel-group park study to compare the onset of action of fluticasone propionate aqueous nasal spray 200mg QD versus beclomethasone dipropionate aqueous nasal spray 168mg BID in patients with seasonal allergic rhinitis.
FLN-445 Completed A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Park Study to Compare the Onset of Action of Fluticasone Propionate Aqueous Nasal Spray 200µg QD Versus Beclomethasone Dipropionate Aqueous Nasal Spray 168µg BID in Patients with Seasonal Allergic Rhinitis
FLNC02 Completed A double blind comparison of Fluticasone Propionate aqueous nasal spray, Levocabastina nasal spray and placebo in the treatment of patients with seasonal rhinitis to grass pollen. Extensive searching has revealed that no clinical study report is available for this study.
FLNQ12 Completed A double blind, double dummy, placebo controlled trial of fluticasone propionate aqueous nasal spray and oral ketotifen in children with perennial rhinitis aged between 2 and 4 years. Extensive searching has revealed that no clinical study report is available for this study.
FLPB0145 Completed Comparison of fluticasone powder 1mg/day to budesonide powder 1mg/day in deterioration of severe asthma in children: a double-blind, randomised, multicentre study with parallel groups.
FLTA1001 Completed A study to assess the effects of erythromycin on the pharmacokinetics and systemic pharmacodynamics of inhaled fluticasone propionate in healthy volunteers.
FLTA1003 Completed A Phase I Study to Compare the Pharmacokinetics and Pharmacodynamics of Fluticasone Propionate from the 50, 100, 250, and 500mcg DISKUS™ Inhalers
FLTA2001 Completed A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Comparative Trial of Inhaled Fluticasone Propionate Rotadisk® Via Diskhaler 500mcg Bid, Multi-Dose Powder Inhaler 500mcg Bid, and Placebo in Adolescent and Adult Patients with Mild to Moderate Asthma

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.